Progressive Care Inc (RXMD)

[DCorleone]

Differentiating the RXMD "PROMOTION"... that has Clearly become more Evident Today.... with RXMD Facts and Information from RXMD Filings, inclusive of the False Statements made on RXMD, that are PROVEN FALSE by RXMD Filings...

QUOTE: "Again, Thank you for contributing, however, nothing in your post is true."

TOO EASY. Would Recommend a Read just "ONE" RXMD Filing" instead...
LMAO

Declining Margin.
"Gross profit
margins decreased from 31% in 2017 to 23% in 2018, an 8% decrease when compared to 2017."

Declining Profits
"Operating income
decreased by approximately $390,000 in 2018 as compared to 2017."

Declining Reimbursements
"However, revenues were adversely affected by decreases in
compounding reimbursements per claim by third party payors"

Declining Compounding
"compounding revenue decreased from approximately
$1,220,000 from 1,647 claims in first quarter 2017 to approximately $932,000 from 1,678 claims in first quarter 2018."

Declining PPS
.2659>>>>>>>>>>>>>>>>>>>>>>>.065

Declining Volume
https://www.otcmarkets.com/stock/RXMD/overview

Declining Shareholder Equity
Shares Out
426,140,932
05/31/2018

Share-Based Compensation
On January 5, 2018, the Company issued 41,843,571 shares of its Common Stock to its officers, directors and
employees as stock-based compensation. The shares were issued in consideration of services provided to the
Company in 2017 and were initially valued on the grant date at $577,629. The requisite service period for the stock
grants was one year based on the vesting period of each stock grant. The Company has elected to estimate forfeitures
with subsequent true-up to actual experience. The compensation cost will be recognized as expense ratably over the
requisite service period. Total share-based compensation expense related to the stock grants was $142,429 for the
three months ended March 31, 2018.